Immatics (IMTX)
(Delayed Data from NSDQ)
$6.18 USD
-0.14 (-2.22%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $6.30 +0.12 (1.94%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Immatics N.V. has a market cap of $768.20M, which represents its share price of $6.32 multiplied by its outstanding shares number of 121.55M. As a small-cap company, IMTX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
IMTX 6.18 -0.14(-2.22%)
Will IMTX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IMTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IMTX
Dynavax Technologies (DVAX) Q2 Earnings and Revenues Beat Estimates
Does Immatics (IMTX) Have the Potential to Rally 174.54% as Wall Street Analysts Expect?
IMTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
ImmunityBio (IBRX) Reports Q1 Loss, Tops Revenue Estimates
Cardiff Oncology (CRDF) Reports Q1 Loss, Lags Revenue Estimates
Day One Biopharmaceuticals, Inc. (DAWN) Reports Q1 Loss, Tops Revenue Estimates
Other News for IMTX
IMTX Makes Bullish Cross Above Critical Moving Average
Iovance Biotherapeutics: ASCO Update, Competitor Data And The Road Ahead
Immatics N.V. Shareholders Approve Key Resolutions at June 2025 AGM
Tracking Baker Brothers Portfolio - Q1 2025 Update
Immatics: Taking Off On A PRAME Rocketship